Calculus Capital’s thesis focuses on scaling UK-based companies that have reached proof of concept and are ready for expansion. The firm leverages the UK’s EIS and VCT structures to provide growth and later-stage capital to companies demonstrating solid fundamentals, recurring revenue, and clear exit potential. Calculus invests in technology and healthcare sectors where innovation meets commercial scalability, seeking to deliver long-term investor returns through disciplined value creation and active portfolio management.